Galderma Group AG (XSWX:GALD) Total Operating Expense: CHF2,199 Mil (TTM As of Dec. 2025)


XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF185.80
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Total Operating Expense?

Galderma Group AG XSWX:GALD +4.24% 15 Total Operating Expense is CHF2,199 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Galderma Group AG's Total Operating Expense for the six months ended in Dec. 2025 was CHF1,128 Mil. Galderma Group AG's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF2,199 Mil.

Galderma Group AG Total Operating Expense Related Terms

Galderma Group AG Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Total Operating Expense Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
1,891.64 2,071.79 1,966.56 2,146.08 2,177.93

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial 985.87 1,102.06 1,046.74 1,070.98 1,128.41
XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF2,199 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of CHF2,199 Mil mean?
Galderma Group AG (XSWX:GALD) has a Total Operating Expense of CHF2,199 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Total Operating Expense too high?
Galderma Group AG's current Total Operating Expense is CHF2,199 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Total Operating Expense compare to ZTS and UTHR?
Galderma Group AG's Total Operating Expense of CHF2,199 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Total Operating Expense is CHF2,199 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Total Operating Expense of CHF2,199 Mil. The current Total Operating Expense is CHF2,199 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Total Operating Expense is CHF2,199 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF185.80
Price